Table 2.
Phenodex-FlorMore | |||||||
---|---|---|---|---|---|---|---|
Patient | Skin | Eye | Gastro intestinal | Vascular | Cardiac | Renal | |
#1 | 3 | 4 | 0 | 0 | 0 | 0 | |
#2 | 2 | 4 | 0 | 2 | 1 | 0 | |
#3 | 3 | 6 | 0 | 0 | 0 | 0 |
Axillary and arm areas show typical skin papules and laxity (CAS=clinically affected skin) and absence of skin alterations (CUS clinically unaffected skin), respectively. The Phenodex-FlorMore scoring system for the evaluation of PXE clinical manifestations. Image is published with the informed consent of the patient.